Pfizer EBITDA 2012-2026 | PFE

Pfizer EBITDA for the quarter ending March 31, 2026 was $5.513B, a 17.89% decline year-over-year.

  • Pfizer 2024 EBITDA was 19.424B, a 156.63% increase from 2023.
  • Pfizer 2023 EBITDA was 7.569B, a 81.47% decline from 2022.
  • Pfizer 2022 EBITDA was 40.853B, a 65.91% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Pfizer EBITDA 2012-2026 | PFE

  • Pfizer 2024 EBITDA was 19.424B, a 156.63% increase from 2023.
  • Pfizer 2023 EBITDA was 7.569B, a 81.47% decline from 2022.
  • Pfizer 2022 EBITDA was 40.853B, a 65.91% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B